2007
DOI: 10.1016/j.ajo.2007.07.035
|View full text |Cite
|
Sign up to set email alerts
|

Long-term Outcomes of Ahmed Glaucoma Valve Implantation in Refractory Glaucomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

14
105
2
8

Year Published

2009
2009
2019
2019

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 151 publications
(129 citation statements)
references
References 36 publications
14
105
2
8
Order By: Relevance
“…Indeed, a valve mechanism has been introduced in an attempt to prevent complications sometimes encountered with non-valved GDIs, such as hypotony, shallow anterior chamber, choroidal effusion and choroidal detachment [14]. Several studies have shown that AGV is safe and effective in reducing IOP in patients with primary [15][16][17], secondary [18][19][20][21][22][23][24] and refractory glaucoma [25][26][27]. However, the hypotensive efficacy of AGV in comparison with other anti-glaucoma interventions has not been completely elucidated.…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, a valve mechanism has been introduced in an attempt to prevent complications sometimes encountered with non-valved GDIs, such as hypotony, shallow anterior chamber, choroidal effusion and choroidal detachment [14]. Several studies have shown that AGV is safe and effective in reducing IOP in patients with primary [15][16][17], secondary [18][19][20][21][22][23][24] and refractory glaucoma [25][26][27]. However, the hypotensive efficacy of AGV in comparison with other anti-glaucoma interventions has not been completely elucidated.…”
Section: Introductionmentioning
confidence: 99%
“…Seton implantlarının, medikal tedavi ve filtran cerrahilere rağmen kontrol altına alınamayan olgularda GİB'i düşürmede etkili olduğu gösterilmiştir [3,8]. Seton cerrahisi sonrasında hifema, hipotoni, korneal ödem, tüp exposure, sığ ön kamara gibi çeşitli komplikasyonlar görülmektedir.…”
Section: Discussionunclassified
“…Ahmed glaucoma valve 5,6 is an established modality of management of advanced glaucoma cases withcumulative probability of successful outcome reported from different studies ranges from 76% to 87% at 1 year and 68% to 77% at 2 years [7][8][9] . Several early and late postoperative complications 3 have been reported in the literature including transient hypotony (19.5%), shallow anterior chamber (14.5%), tube blockage (11.3%), hemorrhage (7.2%),encapsulated bleb ( hypertensive phase)(10.9%), exposure of tube (5.0%), tube malposition (4.5%), corneal decompensation (2.3%),extrusion of implant (1.4%), and rarely endophthalmitis (1.7%) 4 .…”
Section: Discussionmentioning
confidence: 99%